Alector, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Alector, Inc. (ALEC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $42.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-25
- Alector, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $42.90M, a 60.67% increase from fiscal 2024.
- Alector, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $26.70M, a 33.58% decline from fiscal 2023.
- Alector, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $40.20M, a 4.96% decline from fiscal 2022.
- Alector, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $42.30M, a 151.79% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $42.90M 10-K · filed 2026-02-25 |
| 2024-12-31 | $26.70M 10-K · filed 2025-02-26 |
| 2023-12-31 | $40.20M 10-K · filed 2024-02-27 |
| 2022-12-31 | $42.30M 10-K · filed 2023-02-28 |
| 2021-12-31 | $16.80M 10-K · filed 2022-02-24 |
| 2020-12-31 | $58.20M 10-K · filed 2021-02-25 |
| 2019-12-31 | $29.80M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |